Evidence map›Paper›PMID 33557818›Full record

ArticleBMC medical informatics and decision making2021

Predicting COVID-19 disease progression and patient outcomes based on temporal deep learning.

Chenxi Sun, Shenda Hong, Moxian Song, Hongyan Li, Zhenjie Wang

Abstract read
In one paragraph

Article in BMC medical informatics and decision making, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Adaptive model training strategy for continuous classification of time series.Applied intelligence (Dordrecht, Netherlands) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chenxi SunSchool of Electronics Engineering and Computer Science, Peking University, Beijing, People's Republic of China.
Shenda HongNational Institute of Health Data Science, Peking University, Beijing, People's Republic of China.
Moxian SongSchool of Electronics Engineering and Computer Science, Peking University, Beijing, People's Republic of China.
Hongyan LiSchool of Electronics Engineering and Computer Science, Peking University, Beijing, People's Republic of China. leehy@pku.edu.cn.
Zhenjie WangInstitute of Population Research, Peking University, No.5 Yiheyuan Road, Beijing, 100871, People's Republic of China. zhenjie.wang@pku.edu.cn.ORCID 0000-0003-1717-5790

Funding

National Key Research and Development Program of China 2020YFB2103402Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry and UKRI's Global Challenge Research Fund ES/P011055/1
6 · The paper itself

Abstract

backgroundThe coronavirus disease 2019 (COVID-19) pandemic has caused health concerns worldwide since December 2019. From the beginning of infection, patients will progress through different symptom stages, such as fever, dyspnea or even death. Identifying disease progression and predicting patient outcome at an early stage helps target treatment and resource allocation. However, there is no clear COVID-19 stage definition, and few studies have addressed characterizing COVID-19 progression, making the need for this study evident.

methodsWe proposed a temporal deep learning method, based on a time-aware long short-term memory (T-LSTM) neural network and used an online open dataset, including blood samples of 485 patients from Wuhan, China, to train the model. Our method can grasp the dynamic relations in irregularly sampled time series, which is ignored by existing works. Specifically, our method predicted the outcome of COVID-19 patients by considering both the biomarkers and the irregular time intervals. Then, we used the patient representations, extracted from T-LSTM units, to subtype the patient stages and describe the disease progression of COVID-19.

resultsUsing our method, the accuracy of the outcome of prediction results was more than 90% at 12 days and 98, 95 and 93% at 3, 6, and 9 days, respectively. Most importantly, we found 4 stages of COVID-19 progression with different patient statuses and mortality risks. We ranked 40 biomarkers related to disease and gave the reference values of them for each stage. Top 5 is Lymph, LDH, hs-CRP, Indirect Bilirubin, Creatinine. Besides, we have found 3 complications - myocardial injury, liver function injury and renal function injury. Predicting which of the 4 stages the patient is currently in can help doctors better assess and cure the patient.

conclusionsTo combat the COVID-19 epidemic, this paper aims to help clinicians better assess and treat infected patients, provide relevant researchers with potential disease progression patterns, and enable more effective use of medical resources. Our method predicted patient outcomes with high accuracy and identified a four-stage disease progression. We hope that the obtained results and patterns will aid in fighting the disease.

Indexed as

COVID-19Deep LearningDisease ProgressionChinaForecastingHumansSARS-CoV-2COVID-19Disease progressionIrregularly sampled time seriesOutcome early predictionTime-aware long short-term memory

Identifiers

PMID33557818
PMCPMC7869774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.